Rodríguez DM, Mulet PA, Arencibia VÉ, Mencos ADE, Miranda MZ, González BA

Language: Spanish
References: 0
Page: 593-606
PDF size: 399.38 Kb.

ABSTRACT

Introduction: intrahepatic cholestasis of pregnancy, a condition with variable clinical and analytic expressions, involves risk for the fetus.
Objective: to identify the clinical, biochemical expression and perinatal outcome in patients with cholestasis intrahepatic of pregnancy.
Method: descriptive observational prospective investigation from March 2012 to February 2014, at Vladimir Ilich Lenin Hospital, in Holguín. A group of 43 patients with intrahepatic colestasis of pregnancy, out of 68 admitted patients with hepatobiliary conditions with selection criteria, were included. Interrogatory, physical examination and clinical records were data sources. Mann-Whitney U and Fisher statistical tests were applied. Clinical manifestations were classified into milled or severe, and perinatal outcome in favorable or unfavorable.
Results: the 58.1% were preterm newborns; 25.6% had low birth weight and 23.3% had a low Apgar score. Alanine aminotransferase and aspartate aminotransferase were the most increased laboratory tests with 3.2 y 2.2 times over the upper limit of normal, each. Alanine aminotransferase, aspartate aminotransferase, bilirubin and prothrombin time values were significantly higher in the most symptomatic group with 37.2%. Bilirubin and triglycerides were significantly higher in the group with unfavorable perinatal outcome with 74.4%. There was a significant association (p = 0.003) between the severity of clinical manifestations and perinatal outcome.
Conclusions: present study results favor future research development and rigorous clinical and biochemical predictors designs for worst fetal prognosis, in our clinical settings.